Avadel pharmaceuticals to present at the svb securities global biopharma conference

Dublin, ireland, feb. 08, 2023 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the svb securities global biopharma conference on wednesday, february 15 at 1:00 p.m. et.
AVDL Ratings Summary
AVDL Quant Ranking